ArticleCureus2023
A Case of a Patient With Cannabis Hyperemesis Syndrome Along With Recurrent Nephrolithiasis.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Unraveling the Enigma of Cannabinoid Hyperemesis Syndrome: A Narrative Review of Diagnosis and Management.Cureus · 2025Review
- Article
- Cannabis Hyperemesis Syndrome: What Do We Know?Medical cannabis and cannabinoidsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabis hyperemesis syndrome (CHS) is a condition characterized by cyclic vomiting and abdominal pain in chronic cannabis users. It is caused by long-term cannabis use and is often misdiagnosed or unrecognized. CHS can lead to dehydration, electrolyte imbalances, and renal failure, exacerbating the risk of nephrolithiasis or kidney stones. Nephrolithiasis is a common urologic condition characterized by the formation of solid stones in the kidneys, ureters, or bladder. The association between CHS and nephrolithiasis is still unclear and requires further investigation. However, it is suggested that CHS may increase the risk of nephrolithiasis due to dehydration and electrolyte imbalances. Therefore, healthcare professionals should be aware of the potential complications of CHS and monitor patients for kidney stones, especially in chronic cannabis users. We report a case of a 28-year-old American-Indian male with a history of daily marijuana use, presented with recurrent renal stones and acute colicky pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.